ANDROGENIX PHARMACEUTICALS LTD

Company number 09939083

Date	Type	Description	View / Download
16 Jan 2018	GAZ2(A)	Final Gazette dissolved via voluntary strike-off	(1 page)
31 Oct 2017	GAZ1(A)	First Gazette notice for voluntary strike-off	(1 page)
19 Oct 2017	DS01	Application to strike the company off the register	(3 pages)
16 Jan 2017	CS01	Confirmation statement made on 5 January 2017 with updates	(6 pages)
03 Aug 2016	AD01	Registered office address changed from 17 Cavendish Square London W1G 0PH United Kingdom to 5 Fleet Place London EC4M 7rd on 3 August 2016	(1 page)
29 Apr 2016	RESOLUTIONS	Resolutions RES10 ‐ Resolution of allotment of securities RES11 ‐ Resolution of removal of pre-emption rights	(2 pages)
21 Apr 2016	SH01	Statement of capital following an allotment of shares on 16 March 2016 GBP 350	(3 pages)
19 Apr 2016	SH02	Sub-division of shares on 16 March 2016	(5 pages)
11 Apr 2016	TM01	Termination of appointment of Mark Bonar as a director on 4 April 2016	(1 page)
22 Mar 2016	AP01	Appointment of Dr Mark Bonar as a director on 16 March 2016	(2 pages)
22 Mar 2016	AP01	Appointment of Dr Yassine Bendiabdallah as a director on 16 March 2016	(2 pages)
09 Mar 2016	AD03	Register(s) moved to registered inspection location 5 Fleet Place London EC4M 7rd	(1 page)
08 Mar 2016	AD01	Registered office address changed from 5 Fleet Place London EC4M 7rd England to 17 Cavendish Square London W1G 0PH on 8 March 2016	(1 page)
08 Mar 2016	AD02	Register inspection address has been changed to 5 Fleet Place London EC4M 7rd	(1 page)
21 Jan 2016	AA01	Current accounting period shortened from 31 January 2017 to 31 December 2016	(1 page)
06 Jan 2016	NEWINC	Incorporation Statement of capital on 2016-01-06 GBP 1	(32 pages)